[1] 郑家伟,周琴,王延安,等.口腔颌面部血管瘤治疗指南[J].中国口腔颌面外科杂志, 2011, 9(1):61-67.
[2] 唐东方,尤金良,李伟,等.新生儿幼年性巨大毛细血管瘤1例报告[J].中风与神经疾病杂志,2018,35(1):81-82.
[3] Francois M, Harvey NL, Hogan BM. The transcriptional control of lymphatic vascular development[J]. Physiology (Bethesda),2011,26(3):146-155.
[4] 钱世宁,朱小飞,季明德,等.含人SOX18基因真核表达载体的构建及其重组蛋白诱导血管内皮细胞增殖的研究[J].南京医科大学学报(自然科学版),2018,38(2):166-170.
[5] Wang G, Wei Z, Jia H, et al. Knockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells[J]. Oncol Rep, 2015,34(3):1121-1128.
[6] Yang N, Wang Y, Hui L, et al. SOX 1, contrary to SOX 2, suppresses proliferation, migration, and invasion in human laryngeal squamous cell carcinoma by inhibiting the Wnt/β-catenin pathway[J]. Tumour Biol, 2015,36(11):8625-8635.
[7] Xu YR, Yang WX. SOX-mediated molecular crosstalk during the progression of tumorigenesis[J]. Semin Cell Dev Biol,2017,63:23-34.
[8] Fran?觭ois M, Caprini A, Hosking B, et al. Sox18 induces development of the lymphatic vasculature in mice[J]. Nature, 2008,456(7222):643-647.
[9] 马丽莉. SOX18,血管内皮生长因子C(VEGF-C)和血管内皮生长因子受体3(VEGFR-3)在胃癌中的表达及意义[D]. 长沙: 中南大学,2012.
[10] Young N, Hahn CN, Poh A, et al. Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development[J]. J Natl Cancer Inst, 2006,98(15):1060-1067.
[11] Duong T, Proulx ST, Luciani P, et al. Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice[J] Cancer Res, 2012,72(12):3105-3114.
[12] Huaqi Y, Caipeng Q, Qiang W, et al. The role of SOX18 in bladder cancer and its underlying mechanism in mediating cellular functions[J]. Life Sci, 2019, 232:116614.
[13] Miao Z, Deng X, Shuai P, et al.Upregulation of SOX18 in colorectal cancer cells promotes proliferation and correlates with colorectal cancer risk[J]. Onco Targets Ther, 2018,11:8481-8490.
[14] Matsui T, Kanai-Azuma M, Hara K, et al. Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice[J]. J Cell Sci, 2006, 119(Pt 17):3513-3526.
[15] Cermenati S, Moleri S, Cimbro S, et al. Sox18 and Sox7 play redundant roles in vascular development[J]. Blood, 2008, 111(5):2657-2666.
[16] Herpers R, van de Kamp E, Duckers HJ, et al. Redundant roles for sox7 and sox18 in arteriovenous specification in zebrafish[J]. Circ Res, 2008, 102(1):12-15.
[17] Zhu W, Wang Y, Zhang D, et al. MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma[J]. Biochem Biophys Res Commun, 2018, 497(4):963-970.
[18] Petrovic I, Kovacevic-Grujicic N, Stevanovic M. Early growth response protein 1 acts as an activator of SOX18 promoter[J]. Exp Mol Med, 2010, 42(2):132-142.
[19] Yin H, Sheng Z, Zhang X, et al. Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7[J]. Oncol Rep, 2017, 37(2):1045-1051.
[20] Xu Y, Zhang Q, Zhou J, et al. Down-regulation of SOX18 inhibits laryngeal carcinoma cell proliferation, migration, and invasion through JAK2/STAT3 signaling[J]. Biosci Rep,2019, 39(7) .
[21] Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele[J]. Nature, 1996, 380(6573):435-439.
[22] Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene[J]. Nature, 1996, 380(6573):439-442.
[23] Liang S, Yu H, Chen X, et al. PDGF-BB/KLF4/VEGF Signaling Axis in Pulmonary Artery Endothelial Cell Angiogenesis[J]. Cell Physiol Biochem, 2017,41(6):2333-2349.
[24] Choi D, Park E, Jung E, et al. ORAI1 Activates Proliferation of Lymphatic Endothelial Cells in Response to Laminar Flow Through Krüppel-Like Factors 2 and 4[J]. Circ Res, 2017, 120(9):1426-1439. |